CTXR Citius Pharmaceuticals, Inc.
Price Chart
Executive Summary
The SEC declared effective Citius Pharmaceuticals' S-3 shelf registration (File No. 333-296195) on June 2, 2026. This enables the resale of 5,431,473 shares underlying warrants issued in the April 2026 registered direct offering, creating immediate overhang of ~20% of shares outstanding. The company receives no proceeds from resales, though warrant cash exercise could yield up to $4.8M.
Actionable Insight
The shelf effectiveness enables immediate warrant-share resales, likely pressuring CTXR's stock price given the ~20% overhang and distressed financials (going-concern, $4.6M cash). Monitor for selling volume spikes and any Nasdaq delisting update. The $4.8M potential cash exercise is insufficient to address the cash burn.
Key Facts
- Effectiveness date: June 2, 2026 for S-3 shelf registration (File No. 333-296195)
- Registration covers 5,431,473 shares of common stock for resale by selling stockholders
- Shares are underlying warrants issued in the April 2026 registered direct offering
- Company will not receive any proceeds from resales; potential $4.8M if all warrants exercised for cash
- Overhang equivalent to ~20% of current shares outstanding, led by Armistice Capital
- Filed 12 days after the S-3 registration statement (May 22, 2026)
- Company faces going-concern risk, Nasdaq bid price non-compliance, and depleted cash runway of $4.6M
Financial Impact
Overhang of ~20% of shares outstanding; potential $4.8M cash inflow if all warrants exercised, but no proceeds from resales
Risk Factors
- Immediate selling pressure from warrant holders (Armistice Capital) into thin liquidity
- Nasdaq delisting if bid price remains below $1.00
- Going-concern risk with only $4.6M cash runway
- Dilution overhang may deter new investors
Market Snapshot
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-001857 |
| Document: 9999999995-26-001857-index.html | 9999999995-26-001857 |
| Document: 9999999995-26-001857.txt | 9999999995-26-001857 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 3, 2026
12d ago
|
EFFECT
| $0.5800 $0.5900 | ▼ −1.72% | ▼ −1.33% | $0.5400 (+6.90%) |
|
Jun 1, 2026
13d ago
|
8-K
| $0.6030 $0.5800 | ▼ −3.81% | ▼ −3.09% | $0.5400 (−10.45%) |
|
May 22, 2026
23d ago
|
S-3
| $0.6970 $0.6900 | ▲ +1.00% | ▲ +1.02% | $0.5400 (+22.53%) |
|
May 15, 2026
4w ago
|
8-K
| $0.5270 $0.5540 | ▼ −5.12% | ▼ −5.77% | $0.5400 (−2.47%) |
|
Apr 24, 2026
7w ago
|
8-K
| $0.6910 $0.6500 | ▲ +5.93% | ▲ +5.45% | $0.5400 (+21.85%) |
|
Apr 24, 2026
7w ago
|
424B5
| $0.7700 $0.6910 | ▲ +10.26% | ▲ +10.42% | $0.5400 (+29.87%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access